Drug Shortage Report for TARO-SUMATRIPTAN

Last updated on 2018-06-18 History
Report ID 6953
Drug Identification Number 02361698
Brand name TARO-SUMATRIPTAN
Common or Proper name SUMATRIPTAN
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 6MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2x0.5mL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-23
Estimated end date 2018-06-07
Actual end date 2018-06-15
Shortage status Resolved
Updated date 2018-06-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v37 2018-06-18 French Compare
v36 2018-06-18 English Compare
v35 2018-05-25 French Compare
v34 2018-05-25 English Compare
v33 2018-04-13 French Compare
v32 2018-04-13 English Compare
v31 2018-03-16 French Compare
v30 2018-03-16 English Compare
v29 2018-01-19 French Compare
v28 2018-01-19 English Compare
v27 2018-01-18 French Compare
v26 2018-01-18 English Compare
v25 2017-12-25 French Compare
v24 2017-12-25 English Compare
v23 2017-12-04 French Compare
v22 2017-12-04 English Compare
v21 2017-11-17 French Compare
v20 2017-11-17 English Compare
v19 2017-11-03 French Compare
v18 2017-11-03 English Compare

Showing 1 to 20 of 37